Monogenic Short Stature and the Promise of Identifying Genetic Etiologies: An Expert Interview
Endocrinology Advisor spoke with Dr Andrew Dauber about the possible benefits of genetic testing for diagnosing short stature.
All articles by Rachael Beairsto
Abdominal Obesity Associated With Increased Risk for Ischemic Stroke
Increased waist-to-hip ratio is associated with a higher risk for ischemic stroke and may predict stroke risk more accurately than measures of body mass index.
Metformin, Newer Oral Medications Linked to Better Cognitive Performance in T2D
Older men with type 2 diabetes who received metformin or newer hypoglycemic medication had less cognitive decline compared with those who received sulfonylureas.
Risk for Fournier Gangrene Identified With SGLT2 Inhibitor Use in Type 2 Diabetes
Clinicians should be aware of an increased risk for Fournier gangrene in patients with diabetes receiving sodium-glucose cotransporter 2 inhibitors.
Teprotumumab Effectively Reduces Proptosis in Active Thyroid Eye Disease
Teprotumumab effectively reduces proptosis in patients with active thyroid eye disease.
Low Rates of Osteoporosis Screening in Patients With Recent Stroke Despite High Fracture Risk
Rates of osteoporosis screening and treatment are low in patients with recent stroke despite elevated risk for low-trauma fracture.
Endocrine Society Supports European Parliament’s Call for Endocrine-Disrupting Chemical Regulation
The Endocrine Society commended the new resolution from the European Parliament addressing regulation of endocrine-disrupting chemicals.
Addressing Obesity Stigma and Metabolic Surgery in T2D: Takeaways From WCITD 2019
Surgeons, endocrinologists, and other stakeholders in the field came together to discuss challenges in diabetes and obesity care at the 4th World Congress on Interventional Therapies for Type 2 Diabetes.
Expert Interview: What Endocrinologists Should Take Away From WCITD 2019
Endocrinology Advisor sat down with David Nathan, MD, Director of the Diabetes Center at Massachusetts General Hospital in Boston, Massachusetts, to discuss takeaways for endocrinologists from the 4th World Congress on Interventional Therapies for Type 2 Diabetes (WCITD), held April 8 to 10, 2019, in New York City. Endocrinology Advisor: Could you discuss your opinion…
Experts Convene at WCITD 2019 to Discuss Metabolic Surgery in T2D
WCITD 2019 welcomed attendees from more than 55 countries to discuss the latest data analyzing the effects of bariatric surgery on remission of type 2 diabetes.
Next post in Type 2 Diabetes
